Skip to main content
. 2015 Feb 1;31(1):11–16. doi: 10.1089/jop.2014.0100

FIG. 2.

FIG. 2.

AUC(0–tlast) in ocular tissues following intravitreal administration of the FAc implant. Based on the AUC(0–tlast) (ng*h/g) exposure to FAc increased by dose as expected. The value for the low dose group is disproportionately smaller because this group received a single intravitreal implant on day 1 while the 0.5 and 1.0 μg/day groups received a second dose at month 12.